Australis Capital Inc. (AUSAF)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Aug 27, 2025, 8:00 PM EDT
Australis Capital Market Cap
Australis Capital has a market cap or net worth of $25.42 thousand as of August 29, 2025. Its market cap has decreased by -99.90% in one year.
Market Cap
25.42K
Enterprise Value
n/a
Revenue
7.59M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since September 28, 2018, Australis Capital's market cap has decreased from 225.36M to 25.42K, a decrease of -99.99%. That is a compound annual growth rate of -73.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 27, 2025 | 25.42K | -50.00% |
| Dec 31, 2024 | 50.84K | 14,426.86% |
| Dec 29, 2023 | 350.00 | -100.00% |
| Dec 30, 2022 | 7.00M | -80.24% |
| Dec 31, 2021 | 35.42M | 51.38% |
| Dec 31, 2020 | 23.40M | -69.14% |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Sep 28, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.42M |
| Veradigm | 837.26M |
| Elite Pharmaceuticals | 705.48M |
| Tian'an Technology Group | 682.77M |
| Glass House Brands | 661.90M |
| Northwest Biotherapeutics | 443.96M |
| CytoDyn | 393.58M |
| American Oncology Network | 358.34M |